SCHEMBL1869134

SCHEMBL1869134

O=c1cc(-c2cc3sccc3cn2)oc2ccc(O)cc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRM4 Q14833 7/20 0.56
▸ MAPT P10636 5/20 0.53
▸ NPC1 O15118 3/20 0.53
▸ RAB9A P51151 3/20 0.53
▸ TP53 P04637 3/20 0.53
▸ CYP3A4 P08684 3/20 0.53
▸ HPGD P15428 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ ALOX15 P16050 1/20 0.53
▸ CASP3 P42574 1/20 0.53
▸ SENP8 Q96LD8 1/20 0.53
▸ SENP7 Q9BQF6 1/20 0.53
▸ SENP6 Q9GZR1 1/20 0.53
▸ IP6K2 Q9UHH9 1/20 0.53
▸ CALM1 P0DP23 1/20 0.51
▸ PKM P14618 1/20 0.51
▸ FTO Q9C0B1 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1873816 0.86 GRM4 (0.54) GRM4MAPTTP53CYP3A4CSNK2A2
SCHEMBL1870119 0.81 MAPT (0.59) GRM4MAPTNPC1RAB9ATP53
SCHEMBL311667 0.79 CYP3A4 (0.61) MAPTNPC1RAB9ATP53CYP3A4
SCHEMBL1868486 0.78 GRM4 (0.56) GRM4
SCHEMBL1871791 0.75 GRM4 (0.69) GRM4NPC1RAB9ATP53CYP3A4
SCHEMBL1871921 0.72 GRM4 (1.00) GRM4
SCHEMBL1871919 0.72 GRM4 (1.00) GRM4
SCHEMBL17553241 0.72 GRM4 (0.54) GRM4
SCHEMBL13558523 0.72 GRM4 (1.00) GRM4
SCHEMBL19321804 0.72 GRM4 (0.74) GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493871-A1 NOVEL OXIME DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS Domain Therapeutics (FR) 2012-09-05 — — EP disclosed
WO-2011051478-A1 NOVEL OXIME DERIVATIVES AND THEIR USE AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS DOMAIN THERAPEUTICS (FR) 2011-05-05 — — WO disclosed
Send feedback